
    
      Participants are given tablets of 7-methylxanthine 400 mg per day or placebo tablets for 12
      months. Axial length, cycloplegic refraction and corneal curvature is measured, as well as
      weight, height, blood pressure and heart rate. The participants are interviewed about
      possible CNS, gastrointestinal, or cardiopulmonal side effects.
    
  